Andrea Renninger
Senior Director, Regulatory Affairs & Companion Diagnostics Daiichi Sankyo
Andrea is a distinguished leader with two decades of expertise in the realm of clinical trial and biomarker execution, planning, and regulatory strategy. With a focus on precision medicine, Andrea has been instrumental in shaping global regulatory strategies to support the development and delivery of diagnostic tests, enhancing the value of pharmaceutical products across various therapeutic areas.
Seminars
Monday 22nd September 2025
Panel Discussion: Why Diagnostic Regulation Matters in Pharmaceutical Development, & Current Best Practices
5:30 pm
- Identifying the role of diagnostics in pharmaceutical development and the corresponding levels of regulatory expectation
- Providing a high-level summary and comparison of related regulations globally
- Outlining best practices for aligning diagnostic and therapeutic development processes to foster innovation and ensure patient access to precision therapies
